Rac-GTPase, osteoclast cytoskeleton and bone resorption.
The members of the Rho-GTPase subfamily, Rac1 and Rac2, are intimately involved in the organization of the cytoskeleton, and the p21-activated kinases or PAKs are targets of these proteins. Rac1 and Rac2 are also essential components of NADPH oxidase, the enzyme responsible for generating free radicals. The cytoskeleton modulates the adhesion of osteoclasts to bone and its subsequent resorption. These cells contain NADPH diaphorase activity, and free radicals influence bone resorption. The influence of Rac1, Rac2 and PAK1 on the cytoskeleton, resorbing activity and NADPH diaphorase activity of disaggregated rat osteoclasts was investigated by permeabilisation with saponin and introducing specific anti-Rac1, anti-Rac2 or anti-PAK1 antibodies. Rhodamine-phalloidin stain was used to identify actin in osteoclasts cultured on plastic slides, and the bone-slice method was used to measure resorption. Saponin permeabilisation did not affect the cytoskeletal organization or bone resorption. Anti-Rac antibodies caused dose- and time-dependent cytoskeletal changes. The osteoclasts rounded up and developed retraction fibers; actin rings were disrupted and large actin dots were seen at the periphery of the cells. Osteoclast resorptive activity was depressed after incubation with the antibodies. The total area resorbed by treated cells and the mean pit area were smaller than those of controls. Anti-PAK1 antibody caused similar changes. None of the antibodies altered the NADPH diaphorase activity. Thus, Rac-GTPases are present in rat osteoclasts and are involved in the organization of the actin cytoskeleton and in resorptive activity. These effects may be mediated by PAK1 kinase, but do not influence osteoclast NADPH diaphorase activity.
Razzouk
S
S
CNRS-UPR 1524, INRA-LNSA-Bât 221, Jouy en Josas/France.
Lieberherr
M
M
Cournot
G
G
D000199:Actins / Q000378:metabolism; D000818:Animals; D001862:Bone Resorption / Q000378:metabolism*; D003599:Cytoskeleton / Q000378:metabolism*; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D020690:GTPase-Activating Proteins; D009249:NADP / Q000378:metabolism; D010010:Osteoclasts / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000032:analysis; D011506:Proteins / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D015398:Signal Transduction; D013997:Time Factors; D054462:p21-Activated Kinases
D000199:Actins; D020690:GTPase-Activating Proteins; D011506:Proteins; D009249:NADP; D008058:Dihydrolipoamide Dehydrogenase; C515906:Pak1 protein, rat; D017346:Protein Serine-Threonine Kinases; D054462:p21-Activated Kinases